Praxis Precision Medicines (PRAX) Accumulated Expenses (2022 - 2025)
Historic Accumulated Expenses for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $21.6 million.
- Praxis Precision Medicines' Accumulated Expenses rose 3992.37% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 million, marking a year-over-year increase of 3992.37%. This contributed to the annual value of $23.8 million for FY2024, which is 22042.88% up from last year.
- Per Praxis Precision Medicines' latest filing, its Accumulated Expenses stood at $21.6 million for Q3 2025, which was up 3992.37% from $19.0 million recorded in Q2 2025.
- In the past 5 years, Praxis Precision Medicines' Accumulated Expenses registered a high of $30.9 million during Q1 2022, and its lowest value of $7.0 million during Q1 2024.
- In the last 4 years, Praxis Precision Medicines' Accumulated Expenses had a median value of $15.5 million in 2025 and averaged $16.0 million.
- In the last 5 years, Praxis Precision Medicines' Accumulated Expenses crashed by 6976.3% in 2023 and then soared by 22042.88% in 2024.
- Quarter analysis of 4 years shows Praxis Precision Medicines' Accumulated Expenses stood at $15.8 million in 2022, then crashed by 53.21% to $7.4 million in 2023, then soared by 220.43% to $23.8 million in 2024, then dropped by 8.98% to $21.6 million in 2025.
- Its last three reported values are $21.6 million in Q3 2025, $19.0 million for Q2 2025, and $15.5 million during Q1 2025.